If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
33.00    0.55 (1.66%)
Bid:
32.60
Ask:
34.90
Spread: 2.30 (7.055%)
Market Cap: £24.23m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Half Year Trading Update

15 Oct 2015 07:00

RNS Number : 3109C
Carclo plc
15 October 2015
Β 

15 October 2015

Β 

Carclo plc

("Carclo" or "the Group")

Β 

Half year trading update

Β 

The Board is pleased to announce that Carclo has traded well ahead of the comparative period last year and in line with its expectations for the first half of the financial year.Β 

Β 

In Technical Plastics, profits will be ahead of last year's comparative period despite the impact of the weaker Euro on some of our businesses. Our new state of the art Chinese facility in Taicang is now complete and attracting interest from existing and potential new customers and we remain on track to integrate all local activities into the new site prior to the year end. We have continued to develop the Group's site infrastructure and are now close to finalising plans to double the size of our Bangalore, India facility in expectation of significant growth in this market. New business development throughout the division has continued to progress well and we believe this will drive growth over the coming years.

Β 

In LED Technologies, new programme wins in the first half have been in line with expectations and lighting product sales have been strong. We have also secured a flagship vehicle programme for a new major customer and we see significant potential over the next few years to develop this relationship. Whilst this progress is encouraging, one of our other major Group customers, the VW Group ("VW"), this week announced that its flagship luxury vehicle which was due for launch in 2017 will now be launched as an all-electric vehicle. While the full ramifications of this decision on the lighting design are not yet confirmed, we anticipate that this announcement will impact the expected launch date of this vehicle and therefore the timing of anticipated related revenues for our Wipac business.

Β 

As previously highlighted the Precision Engineering division will report operating profits a little behind last year's comparative period due to weakness in the spares segment order book. There are some signs of a strengthening of our order book in this division as we enter the second half.

Β 

Carclo Diagnostic Solutions has continued to meet its development timelines. During the period we have been able to generate excellent technical data on the performance of our Micropoc platform and this will be shown to potential collaborators at forthcoming medical conferences. We have now commissioned a healthcare practitioner review of the Micropoc platforms and intended applications as part of the Board's strategy to continually evaluate the strength of the opportunity given our continued investment in this area.

Β 

The financial position of the Group remains strong. Group debt has increased at the half year, as anticipated following the investment in China, but is expected to decrease from this level by the end of the financial year.

Β 

The Board anticipates that the likely impact of the announcement from VW will mean the Group's full year performance will be marginally below its previous expectations.

Β 

Carclo plc will announce its interim results for the period to 30 September 2015 on 17 November 2015.

- ENDS -

Enquiries:

Β 

Carclo plc

Β 

01924 268040

Chris Malley, Chief Executive

Β 

Β 

Robert Brooksbank, Finance Director

Β 

Β 

Β 

Β 

Β 

Peel Hunt LLP

Β 

0207 418 8900

Justin Jones

Β 

Β 

Jock Maxwell Macdonald

Β 

Β 

Mike Bell

Β 

Β 

Β 

Weber Shandwick

Nick Oborne

Tom Jenkins

Β 

020 7067 0000

Β 

Note to Editors

Β 

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

Β 

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins and support customers the group has been investing in lower cost regions and new technologies.

Β 

Approximately three fifths of revenues are derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTLLFERIALSLIE
Date   Source Headline
12th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
12th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
12th Jul 201811:25 amBUSForm 8.3 - Carclo plc - Ordinary shares
12th Jul 201811:00 amRNSForm 8.3 - Carclo plc
11th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
11th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
10th Jul 20185:50 pmRNSForm 8.3 - [Carclo plc]
10th Jul 20185:27 pmRNSForm 8.3 - [Carclo plc]
10th Jul 20184:10 pmRNSForm 8.3 - [carclo plc]
10th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
10th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
10th Jul 20189:57 amBUSForm 8.3 - Carclo PLC
9th Jul 20183:55 pmRNSForm 8.3 - Carclo plc
9th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
9th Jul 201810:39 amRNSForm 8.3 - Carclo plc
6th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
6th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
5th Jul 201812:09 pmRNSForm 8 (OPD) - CONSORT MEDICAL PLC
5th Jul 201812:08 pmRNSForm 8 (OPD) - Carclo plc
5th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
4th Jul 20183:04 pmRNSHolding(s) in Company
4th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
4th Jul 201810:26 amRNSForm 8.3 - Carclo plc
3rd Jul 20184:22 pmRNSForm 8.3 - Carclo Plc
3rd Jul 20182:33 pmPRNForm 8.3 - Carclo plc
3rd Jul 20182:26 pmRNSForm 8.3 - [Carclo plc]
3rd Jul 20181:56 pmRNSForm 8.3 - Carclo Plc
3rd Jul 20181:49 pmRNSHolding(s) in Company
3rd Jul 20181:32 pmRNSForm 8.3 - Carclo plc
3rd Jul 20181:00 pmRNSForm 8.3 - Carclo plc
3rd Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
3rd Jul 201811:36 amBUSForm 8.3 - Carclo plc - Ordinary shares
3rd Jul 201811:07 amRNSForm 8.3 - [Carclo plc]
2nd Jul 20181:07 pmRNSResponse to announcement from Consort Medical
2nd Jul 20187:00 amRNSNon-Binding Proposal for Carclo plc
28th Jun 20187:00 amRNSBoard changes
6th Jun 201810:27 amRNSHolding(s) in Company
5th Jun 20187:00 amRNSFinal Results
17th Apr 20187:00 amRNSDirectorate Change
9th Apr 20188:25 amRNSYear End Trading Update
26th Jan 20185:25 pmRNSDirector/PDMR Shareholding
24th Jan 201812:43 pmRNSDirector/PDMR Shareholding (Replacement)
24th Jan 201810:12 amRNSDirector/PDMR Shareholding
17th Jan 201811:27 amRNSHolding(s) in Company
16th Jan 201811:44 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSTrading Update and Board Changes
12th Jan 20182:55 pmRNSHolding(s) in Company
12th Jan 20181:45 pmRNSHolding(s) in Company
10th Jan 20185:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.